Arcturus therapeutics to present at the following investor conferences in november

San diego--(business wire)--arcturus therapeutics holdings inc. (the “company,” “arcturus,” nasdaq: arct), a global, late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the company will present at the following investor conferences.
ARCT Ratings Summary
ARCT Quant Ranking